Teachers Retirement System of The State of Kentucky Acquires Shares of 34,789 Transcat, Inc. $TRNS
by Doug Wharley · The Cerbat GemTeachers Retirement System of The State of Kentucky purchased a new stake in shares of Transcat, Inc. (NASDAQ:TRNS – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 34,789 shares of the scientific and technical instruments company’s stock, valued at approximately $1,974,000.
Several other hedge funds and other institutional investors also recently modified their holdings of TRNS. State of Alaska Department of Revenue purchased a new position in shares of Transcat during the third quarter valued at about $40,000. Lazard Asset Management LLC bought a new position in shares of Transcat in the second quarter worth approximately $54,000. Tower Research Capital LLC TRC lifted its stake in shares of Transcat by 245.5% in the second quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company’s stock worth $97,000 after buying an additional 798 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in Transcat by 42.7% during the third quarter. PNC Financial Services Group Inc. now owns 1,530 shares of the scientific and technical instruments company’s stock valued at $112,000 after purchasing an additional 458 shares during the period. Finally, Jones Financial Companies Lllp lifted its position in Transcat by 79.2% during the third quarter. Jones Financial Companies Lllp now owns 1,634 shares of the scientific and technical instruments company’s stock valued at $120,000 after purchasing an additional 722 shares during the period. Hedge funds and other institutional investors own 98.34% of the company’s stock.
Transcat Stock Down 2.1%
Shares of TRNS stock opened at $75.68 on Wednesday. The company has a market capitalization of $706.25 million, a price-to-earnings ratio of 89.04 and a beta of 0.71. Transcat, Inc. has a one year low of $50.23 and a one year high of $97.08. The company’s fifty day moving average price is $76.34 and its 200-day moving average price is $67.61. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.21 and a quick ratio of 1.85.
Transcat (NASDAQ:TRNS – Get Free Report) last announced its quarterly earnings data on Tuesday, February 3rd. The scientific and technical instruments company reported $0.26 EPS for the quarter, missing the consensus estimate of $0.30 by ($0.04). The firm had revenue of $83.86 million for the quarter, compared to the consensus estimate of $80.99 million. Transcat had a net margin of 2.47% and a return on equity of 6.15%. Sell-side analysts expect that Transcat, Inc. will post 1.83 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Separately, Zacks Research downgraded shares of Transcat from a “hold” rating to a “strong sell” rating in a research report on Monday, April 6th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Transcat currently has a consensus rating of “Hold” and an average target price of $105.33.
Read Our Latest Report on TRNS
Transcat Profile
Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.
In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.
See Also
Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS – Free Report).